NEW YORK (GenomeWeb) – Mount Sinai Services today announced a distribution deal with Illumina to offer the Verifi non-invasive prenatal test in Ontario.
Mount Sinai Services said that the deal also provides it flexibility to offer the test in other regions in Canada. Financial and other terms of the deal were not disclosed. Illumina acquired the Verifi test when it purchased Verinata Health in 2013.
Verifi detects trisomies 21, 18, and 13, as well as sex chromosomes for monosomy X, Triple X syndrome, Klinefelter syndrome, and Jacobs syndrome. Additionally, the test helps to stratify the risk for certain X-linked disorders, such as hemophilia, Duchenne muscular dystrophy, or cases of ambiguous genitalia.
Mount Sinai Services is based in Toronto and provides customized laboratory and research services and works with Mount Sinai Hospital's laboratories, clinicians, and researchers.